Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies (MAbS) Global Market Report 2022: By Source, By Application, By End-User" report has been added to ResearchAndMarkets.com's ...

The COVID-19 pandemic has reminded us that no country is immune to the threat posed by emerging infectious diseases. Ensuring prompt, affordable, and equitable global access to potentially life-saving ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

One of the developing roles for biomarkers is to support personalized medicine--to help doctors select those patients who are more or less likely to respond to a particular treatment. In a study ...

Monoclonal antibodies (mAbs) are a class of biologic drugs used to treat rheumatoid arthritis if other treatments aren’t effective. mAbs target specific parts of the immune system to reduce ...